APDN - Applied DNA Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/7/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
38.55M16.32M14.60M10.73M18.94M
Enterprise Value 3
31.37M9.14M15.59M12.44M19.60M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
3.461.040.021.544.29
Price/Book (mrq)
5.302.26N/AN/AN/A
Enterprise Value/Revenue 3
6.3916.5424.617.449.54
Enterprise Value/EBITDA 6
-3.68-3.20-6.15-6.94-14.58

Trading Information

Stock Price History

Beta (5Y Monthly) 0.99
52-Week Change 3-60.69%
S&P500 52-Week Change 35.67%
52 Week High 322.80
52 Week Low 32.52
50-Day Moving Average 38.58
200-Day Moving Average 35.92

Share Statistics

Avg Vol (3 month) 32.04M
Avg Vol (10 day) 3484.87k
Shares Outstanding 54.68M
Float 3.95M
% Held by Insiders 116.45%
% Held by Institutions 119.80%
Shares Short (Jun 14, 2020) 4346k
Short Ratio (Jun 14, 2020) 40.52
Short % of Float (Jun 14, 2020) 48.14%
Short % of Shares Outstanding (Jun 14, 2020) 47.40%
Shares Short (prior month May 14, 2020) 4212.59k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Oct 31, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin -169.31%
Operating Margin (ttm)-174.85%

Management Effectiveness

Return on Assets (ttm)-69.03%
Return on Equity (ttm)-254.80%

Income Statement

Revenue (ttm)4.91M
Revenue Per Share (ttm)2.38
Quarterly Revenue Growth (yoy)-29.00%
Gross Profit (ttm)4.51M
EBITDA -8.29M
Net Income Avi to Common (ttm)-8.63M
Diluted EPS (ttm)-4.18
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.66M
Total Cash Per Share (mrq)1.86
Total Debt (mrq)1.49M
Total Debt/Equity (mrq)20.44
Current Ratio (mrq)5.39
Book Value Per Share (mrq)1.79

Cash Flow Statement

Operating Cash Flow (ttm)-8.21M
Levered Free Cash Flow (ttm)-4.84M